New York, NY, United States of America

Andreas Verras

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 9.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: **Innovative Contributions of Andreas Verras in Pharmaceutical Sciences**

Introduction

Andreas Verras, an accomplished inventor based in New York, NY, has made significant strides in the field of pharmaceutical innovations. With a total of four patents to his name, he has demonstrated a commitment to developing compounds that address critical health issues.

Latest Patents

One of Verras's latest inventions involves indazole derivatives that serve as inhibitors of diacylglyceride O-acyltransferase 2 (DGAT2). This innovative discovery includes a compound represented by formula I and its pharmaceutically acceptable salts. The compounds have potential applications in treating and preventing various diseases mediated by DGAT2, including hepatic steatosis, diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, and cardiorenal diseases such as chronic kidney disease and heart failure.

In another groundbreaking patent, Verras has developed a compound that alters bile acid levels, which may be beneficial for treating diabetes and cardiovascular disease. The compounds defined in this patent also relate to Formula I and are recognized as Cyp8b1 inhibitors, providing a remedial option for individuals suffering from these conditions.

Career Highlights

Andreas Verras has collaborated with prominent organizations such as Merck Sharp & Dohme Corporation and Syngenta Crop Protection, Inc. His work within these leading companies has not only enhanced his expertise but has also contributed to the advancements in pharmaceutical research and development.

Collaborations

Throughout his career, Verras has worked alongside talented colleagues, including Jared N. Cumming and Kevin D. Dykstra. These collaborations have allowed him to leverage diverse perspectives and expertise in the pursuit of innovative solutions in the pharmaceutical landscape.

Conclusion

Andreas Verras embodies the spirit of innovation within the pharmaceutical industry. His dedication to creating effective compounds for treating significant health concerns underscores the importance of research and development in improving public health. With his ongoing contributions, Verras continues to be a pivotal figure in the world of inventions and patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…